CHI's 6th Annual BLOOD PRODUCT SAFETY
	Cambridge Healthtech Institute (CHI) , McLean, Virginia February 14-16, 2000
	Human blood and plasma contain many proteins, the extraction and purification of which are of great medical and economic importance. Transmission of infectious diseases via blood transfusion and the use of processed blood plasma and components have placed a high priority on the development of new strategies for the safety of the blood supply. Screening blood for the detection of infectious agents is continuing to advance but still does not provide complete safety. To further complicate the issue, cost-effectiveness and the threat of emerging and/or crossover infective agents must also be considered. Recent advances and new strategies for the inactivation and removal of infectious agents in whole blood, component concentrates, and plasma is the focal point of CHI’s Sixth Annual Blood Products Safety conference.
	Organized by:	CHI
	Deadline for Abstracts:	January 14, 2000
	Registration:	On-line when brochure is available.
	Email for Requests and Registration:	jlaakso@healthtech.com
	Posted by: Jennifer Laakso   Host: wks137.healthtech.com date: June 23, 1999 20:13:12 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.